{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:49:39Z","timestamp":1787028579267,"version":"build-2736575974"},"reference-count":80,"publisher":"MDPI AG","issue":"23","license":[{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Medical University of Lublin, Poland","award":["DS 360\/2022\u20132024"],"award-info":[{"award-number":["DS 360\/2022\u20132024"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Alcohol-associated liver disease (ALD) is the leading cause of liver-related mortality. In ALD, excessive inflammatory response may induce a massive loss of hepatocytes and lead to irreversible liver damage with progressive fibrosis. Chemokines stimulate the migration of immune cells to the site of inflammation and contribute to the inflammatory cascade that may result in organ failure. We aimed to investigate blood concentrations of CXCL9\/MIG, CXCL10\/IP-10, and CXCL16 chemokines and their diagnostic and prognostic significance in patients with ALD. In a prospective observational study, 88 individuals were recruited, including 63 patients with ALD (44 men and 19 women, aged 48.49 \u00b1 10.88) and 25 healthy control volunteers matched for age, sex, and ethnicity. In blood samples, concentrations of CXCL9\/MIG, CXCL10\/IP-10, and CXCL16 were measured using immunoenzymatic ELISAs. Correlations were examined between CXCL levels and (a) traditional inflammatory markers (C-reactive protein, white blood cell count, neutrophil count, lymphocyte count, and neutrophil-to-lymphocyte ratio-NLR) and (b) liver dysfunction severity scores: Child\u2013Turcotte\u2013Pugh (CTP), MELD-NA, MELD 3.0, and modified Maddrey\u2019s discriminant function (mDF). Patients\u2019 survival within 30 days of hospital admission was recorded for analysis. CXCL capabilities in predicting the severity of liver dysfunction and ALD outcome were validated. ALD patients showed significant systemic upregulation of all studied chemokines compared to the control group. Patients with advanced liver disease, classified as MELD-Na \u2265 20, MELD3.0 &gt; 19, and CTP class C, as well as poor short-term outcomes, presented with significantly higher CXCL9 and CXCL10 levels compared to their counterparts. ALD non-survivors had significantly higher concentrations of all studied CXCLs in comparison to controls. Positive correlations between CXCL16 and CRP, leukocytosis, neutrophils, and NLR were confirmed (0.67; 0.46; 0.48; 0.54, respectively). Although none of the chemokines correlated with ALT activity, CXCL9, CXCL10, and CXCL16 showed positive correlations with bilirubin and alkaline phosphatase and inverse correlations with albumin levels. Our findings revealed the diagnostic and prognostic value of the studied CXCLs in ALD. In particular, CXCL9 and CXCL10 may have potential for discrimination of severe liver dysfunction and poor short-term prognosis. Further multicenter studies are required to confirm our results.<\/jats:p>","DOI":"10.3390\/ijms262311717","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T15:02:48Z","timestamp":1764774168000},"page":"11717","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Diagnostic and Prognostic Potential of CXCL9 and CXCL10 Chemokines in Alcohol-Associated Liver Disease"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-5869-9043","authenticated-orcid":false,"given":"Agnieszka","family":"Szczerbinska","sequence":"first","affiliation":[{"name":"Doctoral School, Medical University of Lublin, 20-950 Lublin, Poland"},{"name":"Department of Clinical Immunology, Medical University of Lublin, 20-950 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4841-6120","authenticated-orcid":false,"given":"Jacek","family":"Rolinski","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology, Medical University of Lublin, 20-950 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0307-7535","authenticated-orcid":false,"given":"Agata","family":"Surdacka","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology, Medical University of Lublin, 20-950 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7337-835X","authenticated-orcid":false,"given":"Halina","family":"Cichoz-Lach","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology with Endoscopy Unit, Medical University of Lublin, 20-090 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,12,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1111\/febs.14466","article-title":"A guide to chemokines and their receptors","volume":"285","author":"Hughes","year":"2018","journal-title":"FEBS J."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Cecchinato, V., Martini, V., Pirani, E., Ghovehoud, E., and Uguccioni, M. (2023). The chemokine landscape: One system multiple shades. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1176619"},{"key":"ref_3","unstructured":"Bruserud, O. (2010). Chemokines in Angiogenesis. The Chemokine System in Experimental and Clinical Hematology, Springer. Available online: http:\/\/link.springer.com\/10.1007\/82_2010_21."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.immuni.2021.01.012","article-title":"Chemokines and the immune response to cancer","volume":"54","author":"Ozga","year":"2021","journal-title":"Immunity"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Karin, N. (2018). Autoantibodies to Chemokines and Cytokines Participate in the Regulation of Cancer and Autoimmunity. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.00623"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0022-1759(02)00419-2","article-title":"Knock out models to dissect chemokine receptor function in vivo","volume":"273","author":"Power","year":"2003","journal-title":"J. Immunol. Methods"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"5226","DOI":"10.4049\/jimmunol.1202909","article-title":"Chemokine Receptor CXCR6-Dependent Hepatic NK T Cell Accumulation Promotes Inflammation and Liver Fibrosis","volume":"190","author":"Wehr","year":"2013","journal-title":"J. Immunol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1084\/jem.185.11.1959","article-title":"Impaired Host Defense, Hematopoiesis, Granulomatous Inflammation and Type 1\u2013Type 2 Cytokine Balance in Mice Lacking CC Chemokine Receptor 1","volume":"185","author":"Gao","year":"1997","journal-title":"J. Exp. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1056\/NEJMra052723","article-title":"The Many Roles of Chemokines and Chemokine Receptors in Inflammation","volume":"354","author":"Charo","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1146\/annurev.immunol.22.012703.104543","article-title":"Chemokines in Innate and Adaptive Host Defense: Basic Chemokinese Grammar for Immune Cells","volume":"22","author":"Rot","year":"2004","journal-title":"Annu. Rev. Immunol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.3748\/wjg.v16.i11.1304","article-title":"Alcohol, inflammation, and gut-liver-brain interactions in tissue damage and disease development","volume":"16","author":"Wang","year":"2010","journal-title":"World J. Gastroenterol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1053\/j.gastro.2014.06.043","article-title":"Roles for Chemokines in Liver Disease","volume":"147","author":"Marra","year":"2014","journal-title":"Gastroenterology"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.cld.2024.06.005","article-title":"Pathogenesis of Alcohol-Associated Liver Disease","volume":"28","author":"Mandrekar","year":"2024","journal-title":"Clin. Liver Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1038\/s41423-025-01291-w","article-title":"Immunological mechanisms and emerging therapeutic targets in alcohol-associated liver disease","volume":"22","author":"Shen","year":"2025","journal-title":"Cell. Mol. Immunol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1146\/annurev-pathmechdis-031521-030435","article-title":"Recent Advances in Understanding of Pathogenesis of Alcohol-Associated Liver Disease","volume":"18","author":"Wu","year":"2023","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Li, W., Gao, W., Yan, S., Yang, L., Zhu, Q., and Chu, H. (2024). Gut Microbiota as Emerging Players in the Development of Alcohol-Related Liver Disease. Biomedicines, 13.","DOI":"10.20944\/preprints202412.0769.v1"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S0140-6736(18)31310-2","article-title":"Alcohol use and burden for 195 countries and territories, 1990\u20132016: A systematic analysis for the Global Burden of Disease Study 2016","volume":"392","author":"Griswold","year":"2018","journal-title":"Lancet"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"101162","DOI":"10.1016\/j.aohep.2023.101162","article-title":"Alcohol-associated liver disease: Epidemiology and management","volume":"29","author":"Pose","year":"2024","journal-title":"Ann. Hepatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1038\/s41591-022-01850-y","article-title":"Noninvasive proteomic biomarkers for alcohol-related liver disease","volume":"28","author":"Niu","year":"2022","journal-title":"Nat. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0140-6736(21)01701-3","article-title":"The EASL\u2013Lancet Liver Commission: Protecting the next generation of Europeans against liver disease complications and premature mortality","volume":"399","author":"Karlsen","year":"2022","journal-title":"Lancet"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1002\/hep.30979","article-title":"Cost-Effectiveness of Noninvasive Screening for Alcohol-Related Liver Fibrosis","volume":"71","author":"Asphaug","year":"2020","journal-title":"Hepatology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/s12276-020-0438-5","article-title":"Recent advances of sterile inflammation and inter-organ cross-talk in alcoholic liver disease","volume":"52","author":"Shim","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Hyun, J., Han, J., Lee, C., Yoon, M., and Jung, Y. (2021). Pathophysiological Aspects of Alcohol Metabolism in the Liver. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22115717"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e176345","DOI":"10.1172\/JCI176345","article-title":"Alcohol-associated liver disease","volume":"134","author":"Mackowiak","year":"2024","journal-title":"J. Clin. Investig."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1053\/j.gastro.2009.03.053","article-title":"Antifibrotic effects of CXCL9 and its receptor CXCR3 in livers of mice and humans","volume":"137","author":"Wasmuth","year":"2009","journal-title":"Gastroenterology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"5642713","DOI":"10.1155\/2023\/5642713","article-title":"Qinggan Huoxue Recipe Protects against Experimental Alcoholic Liver Fibrosis through CXCL16 Inhibition","volume":"2023","author":"Tang","year":"2023","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1053\/j.gastro.2009.01.056","article-title":"Hepatic expression of CXC chemokines predicts portal hypertension and survival in patients with alcoholic hepatitis","volume":"136","author":"Miquel","year":"2009","journal-title":"Gastroenterology"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Brandt, E.F., Baues, M., Wirtz, T.H., May, J.N., Fischer, P., Beckers, A., Sch\u00fcre, B.C., Sahin, H., Trautwein, C., and Lammers, T. (2022). Chemokine CXCL10 Modulates the Tumor Microenvironment of Fibrosis-Associated Hepatocellular Carcinoma. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23158112"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/s41575-021-00444-2","article-title":"Regulation and functional roles of chemokines in liver diseases","volume":"18","author":"Cao","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jhep.2014.09.032","article-title":"CXCL9 is a prognostic marker in patients with liver cirrhosis receiving transjugular intrahepatic portosystemic shunt","volume":"62","author":"Berres","year":"2015","journal-title":"J. Hepatol."},{"key":"ref_31","first-page":"e141420","article-title":"Role of MIF in coordinated expression of hepatic chemokines in Patients with alcohol-associated hepatitis","volume":"6","author":"Poulsen","year":"2021","journal-title":"JCI Insight"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Gopalkrishnan, K., Dodge, J.L., and Lee, B.P. (2025). Significant Liver Disease Among Increased Alcohol Consumers More Than Doubled From 1999 to 2020 Alongside Evolving U.S. Population Demographics. Clin. Gastroenterol. Hepatol.","DOI":"10.1016\/j.cgh.2025.07.006"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e011827","DOI":"10.1136\/bmjopen-2016-011827","article-title":"Birth cohort trends in the global epidemiology of alcohol use and alcohol-related harms in men and women: Systematic review and metaregression","volume":"6","author":"Slade","year":"2016","journal-title":"BMJ Open"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1053\/j.gastro.2016.02.042","article-title":"Standard Definitions and Common Data Elements for Clinical Trials in Patients with Alcoholic Hepatitis: Recommendation From the NIAAA Alcoholic Hepatitis Consortia","volume":"150","author":"Crabb","year":"2016","journal-title":"Gastroenterology"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1097\/HEP.0000000000000885","article-title":"Non-invasive tests for alcohol-associated liver disease","volume":"80","author":"Israelsen","year":"2024","journal-title":"Hepatology"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1007\/s40265-023-01939-9","article-title":"Alcohol-Associated Liver Disease: Evolving Concepts and Treatments","volume":"83","author":"Prince","year":"2023","journal-title":"Drugs"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","article-title":"Molecular and cellular mechanisms of liver fibrosis and its regression","volume":"18","author":"Kisseleva","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"4560","DOI":"10.1038\/s41467-021-24843-w","article-title":"Super enhancer regulation of cytokine-induced chemokine production in alcoholic hepatitis","volume":"12","author":"Liu","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.jhep.2023.05.017","article-title":"The role of neutrophils in alcohol-related hepatitis","volume":"79","author":"Khan","year":"2023","journal-title":"J. Hepatol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.jaut.2010.09.003","article-title":"CXCL10 promotes liver fibrosis by prevention of NK cell mediated hepatic stellate cell inactivation","volume":"35","author":"Hintermann","year":"2010","journal-title":"J. Autoimmun."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.jhep.2014.07.006","article-title":"CXCL10 plays a key role as an inflammatory mediator and a non-invasive biomarker of non-alcoholic steatohepatitis","volume":"61","author":"Zhang","year":"2014","journal-title":"J. Hepatol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"101352","DOI":"10.1016\/j.jcmgh.2024.04.009","article-title":"Inflammation in Alcohol-Associated Hepatitis: Pathogenesis and Therapeutic Targets","volume":"18","author":"Feng","year":"2024","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1097\/HEP.0000000000000924","article-title":"Gut-liver axis: Recent concepts in pathophysiology in alcohol-associated liver disease","volume":"80","author":"Eguileor","year":"2024","journal-title":"Hepatology"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"6963","DOI":"10.1080\/10408398.2025.2455954","article-title":"Regulatory mechanisms of the probiotic-targeted gut\u2013liver axis for the alleviation of alcohol-related liver disease: A review","volume":"65","author":"Yang","year":"2025","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.cmet.2022.09.017","article-title":"Gut-liver axis: Pathophysiological concepts and clinical implications","volume":"34","author":"Tilg","year":"2022","journal-title":"Cell Metab."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"112801","DOI":"10.1016\/j.yexcr.2021.112801","article-title":"MIG\/CXCL9 exacerbates the progression of metabolic-associated fatty liver disease by disrupting Treg\/Th17 balance","volume":"407","author":"Li","year":"2021","journal-title":"Exp. Cell Res."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Wu, X., Yuan, C., Pan, J., Zhou, Y., Pan, X., Kang, J., Ren, L., Gong, L., and Li, Y. (2024). CXCL9, IL2RB, and SPP1, potential diagnostic biomarkers in the co-morbidity pattern of atherosclerosis and non-alcoholic steatohepatitis. Sci. Rep., 14.","DOI":"10.1038\/s41598-024-66287-4"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Zhou, C., Shen, Z., Shen, B., Dai, W., Sun, Z., Guo, Y., Xu, X., Wang, J., Lu, J., and Zhang, Q. (2023). FABP4 in LSECs promotes CXCL10-mediated macrophage recruitment and M1 polarization during NAFLD progression. Biochim. Biophys. Acta BBA\u2014Mol. Basis Dis., 1869.","DOI":"10.1016\/j.bbadis.2023.166810"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"112015","DOI":"10.1016\/j.intimp.2024.112015","article-title":"The role of the CXCR6\/CXCL16 axis in the pathogenesis of fibrotic disease","volume":"132","author":"Wang","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"110530","DOI":"10.1016\/j.intimp.2023.110530","article-title":"Role of the CXCR6\/CXCL16 axis in autoimmune diseases","volume":"121","author":"Bao","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/jvh.13905","article-title":"Serum CXCL16: A new predictor of liver inflammation in patients with chronic hepatitis B","volume":"31","author":"Wan","year":"2024","journal-title":"J. Viral Hepat."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/liv.13610","article-title":"Circulating CXCL 10 in cirrhotic portal hypertension might reflect systemic inflammation and predict ACLF and mortality","volume":"38","author":"Lehmann","year":"2018","journal-title":"Liver Int."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41419-022-04802-z","article-title":"MyD88 in hepatic stellate cells enhances liver fibrosis via promoting macrophage M1 polarization","volume":"13","author":"Zhang","year":"2022","journal-title":"Cell Death Dis."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1089\/jir.2007.0059","article-title":"CXCL10-Producing Mucosal CD4+ T Cells, NK Cells, and NKT Cells Are Associated with Chronic Colitis in IL-10\u2212\/\u2212 Mice, Which Can Be Abrogated by Anti-CXCL10 Antibody Inhibition","volume":"28","author":"Singh","year":"2008","journal-title":"J. Interferon Cytokine Res."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Karin, N. (2020). CXCR3 Ligands in Cancer and Autoimmunity, Chemoattraction of Effector T Cells, and Beyond. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.00976"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Kasztelan-Szczerbinska, B., Slomka, M., Celinski, K., and Szczerbinski, M. (2013). Alkaline Phosphatase: The Next Independent Predictor of the Poor 90-Day Outcome in Alcoholic Hepatitis. BioMed Res. Int., 2013.","DOI":"10.1155\/2013\/614081"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"e0566","DOI":"10.1097\/HC9.0000000000000566","article-title":"Cholestatic insult triggers alcohol-associated hepatitis in mice","volume":"8","author":"Yan","year":"2024","journal-title":"Hepatol. Commun."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.jhep.2018.10.041","article-title":"Alcohol-related liver disease: Areas of consensus, unmet needs and opportunities for further study","volume":"70","author":"Thursz","year":"2019","journal-title":"J. Hepatol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.jceh.2022.02.004","article-title":"Extrahepatic Manifestations in Alcoholic Liver Disease","volume":"12","author":"Nath","year":"2022","journal-title":"J. Clin. Exp. Hepatol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"114750","DOI":"10.1016\/j.yexcr.2025.114750","article-title":"The effect and mechanism of CXCL9 overexpressed umbilical cord mesenchymal stem cells on liver fibrosis in vivo and in vitro","volume":"452","author":"Li","year":"2025","journal-title":"Exp. Cell Res."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1016\/S0140-6736(13)60523-1","article-title":"CXCR6 and CXCL16 in liver disease","volume":"381","author":"Parker","year":"2013","journal-title":"Lancet"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"eabq6509","DOI":"10.1126\/sciimmunol.abq6509","article-title":"CXCL9 and CXCL10 bring the heat to tumors","volume":"7","author":"Reschke","year":"2022","journal-title":"Sci. Immunol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.cytogfr.2025.05.006","article-title":"An emerging paradigm of CXCL16 involvement in cancer progression","volume":"84","author":"Argyris","year":"2025","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMra2026131","article-title":"Cytokine Storm","volume":"383","author":"Fajgenbaum","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Scarlata, G., Colaci, C., Scarcella, M., Dallio, M., Federico, A., Boccuto, L., and Abenavoli, L. (2024). The Role of Cytokines in the Pathogenesis and Treatment of Alcoholic Liver Disease. Diseases, 12.","DOI":"10.20944\/preprints202403.0030.v1"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.3390\/biom5032023","article-title":"Alcoholic Liver Disease: Role of Cytokines","volume":"5","author":"Neuman","year":"2015","journal-title":"Biomolecules"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"241","DOI":"10.15403\/jgld-4660","article-title":"Update on the role of Chemokines and Chemokine Receptors in Liver Fibrosis","volume":"32","author":"Li","year":"2023","journal-title":"J. Gastrointestin. Liver Dis."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"30","DOI":"10.21037\/dmr-21-87","article-title":"Role of the chemokine system in liver fibrosis: A narrative review","volume":"5","author":"Poulsen","year":"2022","journal-title":"Dig. Med. Res."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Xiao, L., Tang, S., Zhang, L., Ma, S., Zhao, Y., Zhang, F., Xie, Z., and Li, L. (2021). Serum CXCL1 Is a Prognostic Factor for Patients with Hepatitis B Virus\u2013Related Acute-On-Chronic Liver Failure. Front. Med., 8.","DOI":"10.3389\/fmed.2021.657076"},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Barber\u00eda-Latasa, M., Gea, A., and Mart\u00ednez-Gonz\u00e1lez, M.A. (2022). Alcohol, Drinking Pattern, and Chronic Disease. Nutrients, 14.","DOI":"10.3390\/nu14091954"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"101200","DOI":"10.1016\/j.jhepr.2024.101200","article-title":"Quantification of alcohol intake in patients with steatotic liver disease and excessive alcohol intake","volume":"7","author":"Hansen","year":"2025","journal-title":"JHEP Rep."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.jhep.2017.04.017","article-title":"Universal screening for alcohol misuse in acute medical admissions is feasible and identifies patients at high risk of liver disease","volume":"67","author":"Westwood","year":"2017","journal-title":"J. Hepatol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1002\/hep.31539","article-title":"Measuring the Alcohol in Alcohol-Associated Liver Disease: Choices and Challenges for Clinical Research","volume":"73","author":"Mellinger","year":"2021","journal-title":"Hepatology"},{"key":"ref_74","unstructured":"(2025, November 13). Alcohol Use Disorders Identification Test (AUDIT-C)\u2014Viral Hepatitis and Liver Disease, Available online: https:\/\/www.hepatitis.va.gov\/alcohol\/treatment\/audit-c.asp."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/hep.27210","article-title":"Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver","volume":"60","author":"Vilstrup","year":"2014","journal-title":"Hepatology"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"(2017). European Association for the Study of the Liver EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. J. Hepatol., 67, 145\u2013172.","DOI":"10.1016\/j.jhep.2017.03.022"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1053\/j.gastro.2021.08.050","article-title":"MELD 3.0: The Model for End-Stage Liver Disease Updated for the Modern Era","volume":"161","author":"Kim","year":"2021","journal-title":"Gastroenterology"},{"key":"ref_78","unstructured":"(2025, November 13). Child-Pugh Score for Cirrhosis Mortality. Available online: https:\/\/www.mdcalc.com\/calc\/340\/child-pugh-score-cirrhosis-mortality."},{"key":"ref_79","unstructured":"(2025, November 13). Medcalculators|MELD 3.0. Available online: https:\/\/medcalculators.stanford.edu\/meld."},{"key":"ref_80","unstructured":"(2025, November 13). Maddrey\u2019s Discriminant Function for Alcoholic Hepatitis. Available online: https:\/\/www.mdcalc.com\/calc\/56\/maddreys-discriminant-function-alcoholic-hepatitis."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/23\/11717\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T10:51:54Z","timestamp":1764931914000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/23\/11717"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,3]]},"references-count":80,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["ijms262311717"],"URL":"https:\/\/doi.org\/10.3390\/ijms262311717","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,3]]}}}